Why Synthetic Genomics Inc Is The Original Synthetic Biology Company

Why Synthetic Genomics Inc Is The Original Synthetic Biology Company

Synthetic Genomics Inc (SGI) is a private company based in La Jolla, California that develops genomic-driven solutions to address global energy and environmental challenges. The company started synthesizing and programing DNA in 2005, long before CRISPR technology greatly improved gene editing techniques. In some ways, the company’s activities appear to be like a sandpit for … Read more

Here’s What Microsoft Is Doing To Defeat COVID-19

Here’s What Microsoft Is Doing To Defeat COVID-19

Last month, Adaptive Biotechnologies Corp. (Nasdaq: ADPT) launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in real time based on de-identified data generated from thousands of COVID-19 blood samples from patients around the globe. The open database contains detailed information … Read more

The Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance Takes On COVID-19

The Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance Takes On COVID-19

Genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts. … Read more

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Pharmaceuticals filed suit against VGXI, a subsidiary of South Korea’s GeneOne Life Sciences, last month, accusing it of not transferring technical details pertaining to manufacturing doses of INO-4800, Inovio’s DNA vaccine compound with promising results against SARS-CoV-2. Inovio details in the lawsuit that VGXI does not possess the capacity to scale up manufacturing, which is essential … Read more

Synthetic Biology Features Prominently In Pershing Square Foundation’s Recent Funding Awards To Fight SARS-CoV-2 Virus

The Pershing Square Foundation recently announced that it has awarded $3 million to nineteen recipients at ten academic research institutions in furtherance of conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combating SARS-CoV-2, The Pershing Square Foundation (the “Foundation”) worked with its … Read more

IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more